5.0
Jul 14, 2021
Current employee, less than 1 year
Sydney
Recommend
CEO approval
Business outlook
Pros
Highly engaging, trusting, collaborative, offers recognition, sister company to Novartis
Cons
Limited resource, continually asks to go above and beyond,